Fayetteville mom rings cancer-free bell after 3-year battle with stage 4 colon cancer
Fayetteville mother Bianca Harvey rang the Sound of Hope bell at Duke Cancer Center on November 20, 2026, celebrating being cancer-free after a three-year battle with stage 4 colon cancer.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Fayetteville mother Bianca Harvey rang the Sound of Hope bell at Duke Cancer Center on November 20, 2026, celebrating being cancer-free after a three-year battle with stage 4 colon cancer. Surrounded by family, friends, and her medical team, Harvey declared, "One, two, three. Cancer free. I did it y'all. Now I'm going to ring the bell for y'all. Y'all ready? Here we go," before ringing the bell, according to WRAL.
Harvey, a competitive bodybuilder and physically active mother, was diagnosed with stage 4 colon cancer more than three years ago. The cancer had already spread by the time it was discovered, making surgery impossible. Her mother, Teresa Harvey, recalled being told her daughter might not survive: "We were told that when we brought her in that they were really planning for a funeral. They didn't think that she would make it." Teresa remembered her daughter saying, "Mom, I'm just so thin. I can't even walk," to which she responded, "That doesn't matter because guess what? I'm on one side and your dad's on the other side, so let's go."
At Duke Health, Harvey worked with Dr. Nicholas DeVito, a medical oncologist specializing in gastrointestinal cancers. With surgery not an option, DeVito turned to clinical trials. Harvey enrolled in a first trial, but after approximately a year the treatment stopped working. A second clinical trial produced a dramatic response: her tumors began shrinking, and scans eventually showed no visible evidence of cancer. Teresa described the effect: "When I think about Dr. D's words, it was like an orange that just died from the inside out. And when they went and did the scan, it was no longer there."
Harvey credited DeVito's determination: "He has fought for me from the very beginning. And when I didn't think there was a way, Dr. DeVito already had the plan mapped out." She added, "That's his field, that's his specialty. So I just believed in him. I believed in him and I believed in God." DeVito said he wants such outcomes to become the norm: "I want this to be the norm. I want people to come in with stage four colon cancers and us to have answers for them. And not just say it's chemotherapy forever."
Harvey acknowledged initial fear about experimental treatment: "At first we were a little scared to try the trial treatments, but the trial treatments are actually the way to go." She has become an advocate for clinical research and hopes other patients will ask their doctors about available options. Harvey first shared her journey in WRAL's 2025 documentary Diagnosis: Young, which examined the rise in cancer diagnoses among younger adults, including colorectal cancer. At the time she was still undergoing treatment and wondering if she would ever celebrate being cancer-free. "Whenever we did that documentary, I remember saying to myself, 'Dang, I'm the only one that still has cancer. Everybody else is cured.' And now I get to, you know, this is the happy end of it. So everybody else gets to also see that too," she said.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 54m ago.
Quick answers
Who is Bianca Harvey and what did she accomplish?
Bianca Harvey is a Fayetteville mother and former competitive bodybuilder who rang the Sound of Hope bell at Duke Cancer Center on November 20, 2026, celebrating being cancer-free after a three-year battle with stage 4 colon cancer.
What treatment approach led to Harvey's remission?
After surgery was ruled out because the cancer had spread, Harvey enrolled in clinical trials at Duke Health under Dr. Nicholas DeVito. A second clinical trial produced a dramatic response, shrinking her tumors until scans showed no visible evidence of cancer.
What did Harvey say about clinical trials and her advice to other patients?
Harvey said she was initially scared to try trial treatments but now believes "the trial treatments are actually the way to go." She has become an advocate for clinical research and hopes other patients will ask their doctors about available treatment options.
Coverage (5)
- After Years of Treatment, Mom Declares ‘Cancer Free!’ at Duke Center People.com · 4h ago
- Winston-Salem Father Completes Stage 4 Colon Cancer Treatment Hoodline · 5h ago
- Mom and Former Bodybuilder Rings Hope Bell After 3-Year Struggle with Colon Cancer Yahoo · 5h ago
- 'Forever grateful': Winston-Salem father rings bell after stage 4 cancer battle WXII · 5h ago
- Fayetteville mom rings cancer-free bell after 3-year battle with stage 4 colon cancer WRAL · 5h ago
Topics
Related trends
This Cancer Kills Children in a Year. Research Has Been Stalled for a Year.
Pediatric brain cancer research faces a year-long stall following the closure of a long-standing research consortium.
Trying Tourette's device was the best day of my life
A wrist-worn nerve-stimulation device developed at the University of Nottingham cut tic frequency by 25% in a 121-person trial and users describe the effect as instant and life-changing.
Experimental weight-loss drug eases painful knee osteoarthritis in two clinical trials
Eli Lilly's experimental triple-hormone drug retatrutide cut knee osteoarthritis pain and produced average weight loss of roughly 25% in two Phase 3 trials involving more than 1,000 adults with obesity.
Pelacarsen, a promising drug for an inherited heart risk, flops, stunning doctors
Medical experts are stunned after the promising cholesterol drug pelacarsen unexpectedly fails a key study, leading to its abandonment.
NEWSLETTER: New blood test matches gold standard for liver disease diagnosis
A new AI-powered blood test called LiquidTransformer matches the accuracy of magnetic resonance elastography in staging MASH and identifying treatment candidates, according to data presented at The Liver Meeting.
Novartis CEO keeps faith in Avidity deal despite taking $1.9B hit from del-desiran fail
Novartis faces a multi-billion dollar financial hit from clinical trial setbacks yet maintains financial guidance.